FIFA Secretary General praises Russian authorities’ commitment to footballSport April 25, 10:14
Israel to hold rally in memory of Red Army VictoryWorld April 25, 8:30
US imposes new sanctions on Syria over suspected chemical attackWorld April 24, 21:23
Russian businessman plans to build sailplane to fly around the globe nonstop in 5 daysScience & Space April 24, 19:50
Roscosmos excludes three cosmonauts from space teamScience & Space April 24, 19:34
Russian Foreign Ministry: Terrorists in Syria may get chemical weapons from Libya, IraqRussian Politics & Diplomacy April 24, 19:05
US not ready yet to restart arms control dialog, Russian diplomat saysRussian Politics & Diplomacy April 24, 18:57
Court recognizes Russia’s Sports Ministry as affected party in WADA whistleblower caseSport April 24, 18:48
Elephant, giraffe and wildcats found among Muscovites’ house petsSociety & Culture April 24, 17:48
GENEVA, March 11. /TASS/. The number of people killed by the Ebola virus disease (EVD) has reached 9,976, the World Health Organization (WHO) said in a report Wednesday.
A total of 24,282 cases of the Ebola virus disease have been reported, the statement said.
In line with statistics, the maximum number of Ebola-related deaths has been registered in Liberia. There have been a total of 4,162 cumulative deaths and 9,343 cumulative cases in the country. Liberia is followed by Sierra Leone (3,629 deaths and 11,619 cases) and Guinea (2,170 and 3,285 respectively).
Separate cases have also been registered in Mali, Nigeria, Senegal, Spain, Britain and the United States.
The Ebola virus disease, previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate.
No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.